

Need a doctor who prescribes Ebglyss for eczema? Learn which specialists to see, how to find a provider near you, and what to expect at your visit.
If you've been dealing with moderate-to-severe atopic dermatitis (eczema) and topical treatments aren't cutting it, you may have heard about Ebglyss (lebrikizumab-lbkz). It's a newer biologic that targets IL-13 — one of the key proteins driving eczema inflammation. But getting a prescription isn't as simple as asking your primary care doctor. Here's how to find the right provider.
Ebglyss is a specialty biologic, which means it's typically prescribed by specialists who treat moderate-to-severe skin conditions. The most common prescribers include:
Your primary care doctor can refer you to one of these specialists if you don't already see one.
Here are several ways to locate a doctor who can prescribe Ebglyss:
When you visit a specialist about Ebglyss, here's what will likely happen:
Be prepared to discuss any previous treatments that didn't work. Insurance companies often require "step therapy," meaning you need to have tried and failed other treatments (like topical steroids or Dupixent) before they'll approve Ebglyss.
Once your doctor prescribes Ebglyss, the next steps include:
Finding the right doctor is the first step toward getting Ebglyss and managing your eczema more effectively. Start with a dermatologist or allergist, and don't hesitate to use telehealth options if local specialists are limited. Once you have a prescription, your provider's office will help navigate insurance and specialty pharmacy logistics.
Ready to find Ebglyss near you? Visit medfinder.com to check availability and get connected.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.